(19)
(11) EP 1 968 561 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.10.2010 Bulletin 2010/42

(45) Mention of the grant of the patent:
15.09.2010 Bulletin 2010/37

(21) Application number: 06849559.7

(22) Date of filing: 22.12.2006
(51) International Patent Classification (IPC): 
A61K 31/10(2006.01)
A61P 3/06(2006.01)
A61P 9/12(2006.01)
 A61P 3/04(2006.01)
A61P 9/10(2006.01)
A61P 13/10(2006.01)
(86) International application number:
PCT/IB2006/004262
(87) International publication number:
WO 2007/125385 (08.11.2007 Gazette 2007/45)

(54)

TREATMENT OF DIABETIC NEPHROPATHY

BEHANDLUNG VON DIABETISCHER NEPHROPATHIE

TRAITEMENT DE LA NEPHROPATHIE DIABETIQUE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 22.12.2005 US 753072 P

(43) Date of publication of application:
17.09.2008 Bulletin 2008/38

(73) Proprietor: Kiacta Sàrl
1806 St-Legier (CH)

(72) Inventors:
  • HAUCK, Wendy
    Quebec H9X 3B6 (CA)
  • HAMET, Pavel
    Quebec H3P 1E1 (CA)

(74) Representative: HOFFMANN EITLE 
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München
81925 München (DE)


(56) References cited: : 
WO-A-01/85093
WO-A-2007/004072
 WO-A-96/28187
US-A1- 2005 143 462
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).